BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33268525)

  • 1. Optimal Expression of the Envelope Glycoprotein of Orthobornaviruses Determines the Production of Mature Virus Particles.
    Sakai M; Fujita Y; Komorizono R; Kanda T; Komatsu Y; Noda T; Tomonaga K; Makino A
    J Virol; 2021 Mar; 95(5):. PubMed ID: 33268525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Borna Disease Virus 2 (BoDV-2) Nucleoprotein Is a Conspecific Protein That Enhances BoDV-1 RNA-Dependent RNA Polymerase Activity.
    Kanda T; Horie M; Komatsu Y; Tomonaga K
    J Virol; 2021 Oct; 95(21):e0093621. PubMed ID: 34406860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of Borna disease virus-based episomal vector under physical and chemical stimulation.
    Yanai M; Sakai M; Komorizono R; Makino A; Tomonaga K
    Microbiol Immunol; 2022 Jan; 66(1):24-30. PubMed ID: 34617609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an RNA Virus-Based Episomal Vector Capable of Switching Transgene Expression.
    Yamamoto Y; Tomonaga K; Honda T
    Front Microbiol; 2019; 10():2485. PubMed ID: 31781052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA Virus-Based Episomal Vector with a Fail-Safe Switch Facilitating Efficient Genetic Modification and Differentiation of iPSCs.
    Komatsu Y; Takeuchi D; Tokunaga T; Sakurai H; Makino A; Honda T; Ikeda Y; Tomonaga K
    Mol Ther Methods Clin Dev; 2019 Sep; 14():47-55. PubMed ID: 31309127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splicing-Dependent Subcellular Targeting of Borna Disease Virus Nucleoprotein Isoforms.
    Kojima S; Sato R; Yanai M; Komatsu Y; Horie M; Igarashi M; Tomonaga K
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a non-transmissive Borna disease virus vector lacking both matrix and glycoprotein genes.
    Fujino K; Yamamoto Y; Daito T; Makino A; Honda T; Tomonaga K
    Microbiol Immunol; 2017 Sep; 61(9):380-386. PubMed ID: 28776750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous expression of both matrix protein and glycoprotein facilitates infectious viral particle production of Borna disease virus 1.
    Kanda T; Sakai M; Makino A; Tomonaga K
    J Gen Virol; 2022 Jul; 103(7):. PubMed ID: 35819821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo biodistribution analysis of transmission competent and defective RNA virus-based episomal vector.
    Komatsu Y; Tanaka C; Komorizono R; Tomonaga K
    Sci Rep; 2020 Apr; 10(1):5890. PubMed ID: 32246020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reverse genetics of parrot bornavirus 4 reveals a unique splicing of the glycoprotein gene that affects viral propagation.
    Komorizono R; Fujino K; Kessler S; Runge S; Kanda T; Horie M; Makino A; Rubbenstroth D; Tomonaga K
    J Virol; 2023 Aug; 97(8):e0050923. PubMed ID: 37578232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolutionary Selection of the Nuclear Localization Signal in the Viral Nucleoprotein Leads to Host Adaptation of the Genus
    Komorizono R; Sassa Y; Horie M; Makino A; Tomonaga K
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33187187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of high-titer transmission-defective RNA virus-based episomal vector using tangential flow filtration.
    Komatsu Y; Kakuya Y; Tomonaga K
    Microbiol Immunol; 2020 Sep; 64(9):602-609. PubMed ID: 32644225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAR2 Is Involved in Self and Nonself Recognition of Borna Disease Virus Genomic RNA in the Nucleus.
    Yanai M; Kojima S; Sakai M; Komorizono R; Tomonaga K; Makino A
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31852792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BUD23-TRMT112 interacts with the L protein of Borna disease virus and mediates the chromosomal tethering of viral ribonucleoproteins.
    Garcia BCB; Horie M; Kojima S; Makino A; Tomonaga K
    Microbiol Immunol; 2021 Nov; 65(11):492-504. PubMed ID: 34324219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral activity of favipiravir (T-705) against mammalian and avian bornaviruses.
    Tokunaga T; Yamamoto Y; Sakai M; Tomonaga K; Honda T
    Antiviral Res; 2017 Jul; 143():237-245. PubMed ID: 28465146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel borna disease virus vector system that stably expresses foreign proteins from an intercistronic noncoding region.
    Daito T; Fujino K; Honda T; Matsumoto Y; Watanabe Y; Tomonaga K
    J Virol; 2011 Dec; 85(23):12170-8. PubMed ID: 21937656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reverse Genetics and Artificial Replication Systems of Borna Disease Virus 1.
    Kanda T; Tomonaga K
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors.
    Bell AJ; Fegen D; Ward M; Bank A
    Exp Biol Med (Maywood); 2010 Oct; 235(10):1269-76. PubMed ID: 20876083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective transduction of astrocytic and neuronal CNS subpopulations by lentiviral vectors pseudotyped with Chikungunya virus envelope.
    Eleftheriadou I; Dieringer M; Poh XY; Sanchez-Garrido J; Gao Y; Sgourou A; Simmons LE; Mazarakis ND
    Biomaterials; 2017 Apr; 123():1-14. PubMed ID: 28152379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced central nervous system transduction with lentiviral vectors pseudotyped with RVG/HIV-1gp41 chimeric envelope glycoproteins.
    Trabalza A; Eleftheriadou I; Sgourou A; Liao TY; Patsali P; Lee H; Mazarakis ND
    J Virol; 2014 Mar; 88(5):2877-90. PubMed ID: 24371049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.